Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$781M |
| 2 |
Amazon
AMZN
|
+$728M |
| 3 |
AABA
Altaba Inc
AABA
|
+$535M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$296M |
| 5 |
Booking.com
BKNG
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$353M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$261M |
| 3 |
Alibaba
BABA
|
+$228M |
| 4 |
Citigroup
C
|
+$170M |
| 5 |
DuPont de Nemours
DD
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.03% |
| 2 | Consumer Discretionary | 1.46% |
| 3 | Financials | 1.01% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VXX
176
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $221M | 0.1% |
4,334,775
-531,850
| -11% | -$30.7M |
|
177
PUT
Pfizer
PFE
$160B
| $214M | 0.09% |
6,720,093
-2,324,492
| -26% | -$73.3M |
|
178
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.8B
| $211M | 0.09% |
3,093,300
-245,200
| -7% | -$16.4M |
|
179
CALL
Mastercard
MA
$509B
| $211M | 0.09% |
1,734,500
+451,600
| +35% | +$53.6M |
|
180
PUT
3M
MMM
$92.3B
| $208M | 0.09% |
1,195,522
-1,423,000
| -54% | -$238M |
|
181
PUT
Salesforce
CRM
$171B
| $207M | 0.09% |
2,390,700
+609,900
| +34% | +$53.1M |
|
182
Invesco QQQ Trust
QQQ
$487B
| $207M | 0.09% |
1,502,878
+780,917
| +108% | +$107M |
|
183
PUT
Starbucks
SBUX
$122B
| $206M | 0.09% |
3,540,300
+196,200
| +6% | +$11.9M |
|
184
PUT
UnitedHealth
UNH
$350B
| $206M | 0.09% |
1,110,500
+94,000
| +9% | +$16.5M |
|
185
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$268M
| $206M | 0.09% |
422
+98
| +30% | +$64.4M |
|
186
CALL
American Airlines Group
AAL
$9.15B
| $205M | 0.09% |
4,077,400
-2,462,300
| -38% | -$114M |
|
187
Costco
COST
$420B
| $204M | 0.09% |
1,274,532
+952,506
| +296% | +$164M |
|
|
188
CALL
UnitedHealth
UNH
$350B
| $203M | 0.09% |
1,096,200
-484,400
| -31% | -$84.9M |
|
189
VanEck Gold Miners ETF
GDX
$32B
| $202M | 0.09% |
9,137,177
-3,688,281
| -29% | -$83.9M |
|
190
CALL
MetLife
MET
$60B
| $201M | 0.09% |
4,113,140
+203,307
| +5% | +$9.43M |
|
191
PUT
Teva Pharmaceuticals
TEVA
$43.5B
| $201M | 0.09% |
6,035,800
+596,900
| +11% | +$18.5M |
|
|
MON
192
CALL
DELISTED
Monsanto Co
MON
| $200M | 0.09% |
1,692,200
+413,300
| +32% | +$48.2M |
|
|
193
CALL
Costco
COST
$420B
| $200M | 0.09% |
1,252,300
+393,200
| +46% | +$67.8M |
|
|
TWX
194
CALL
DELISTED
Time Warner Inc
TWX
| $200M | 0.09% |
1,993,800
+864,300
| +77% | +$85.6M |
|
195
CALL
iShares China Large-Cap ETF
FXI
$4.28B
| $198M | 0.09% |
4,998,000
-1,940,000
| -28% | -$76M |
|
|
196
PUT
MetLife
MET
$60B
| $196M | 0.09% |
3,995,666
+579,625
| +17% | +$26.9M |
|
|
197
CALL
Pfizer
PFE
$160B
| $194M | 0.09% |
6,092,752
-2,001,546
| -25% | -$63.1M |
|
198
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
| $192M | 0.08% |
605,600
-186,400
| -24% | -$58.7M |
|
199
CALL
iShares US Real Estate ETF
IYR
$4.62B
| $192M | 0.08% |
2,402,100
+1,171,600
| +95% | +$93.2M |
|
200
CALL
Nike
NKE
$60.5B
| $190M | 0.08% |
3,221,800
+677,400
| +27% | +$36.5M |
|
Similar funds
Jeff Yass's Q2 2017 Portfolio in Review
As of Q2 2017, Jeff Yass held 10,525 positions worth $228B, up 15% from $198B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Jeff Yass deployed $21.5B of net new capital in Q2 2017, opening 1,702 new positions and adding to 3,804 existing holdings. Its largest new stake was Altaba Inc: 9,835,232 shares worth $536M.
By sector, the portfolio is most concentrated in Technology at 2% of assets, up from 1.2% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $353M trimmed.
- Jeff Yass's largest Q2 2017 buy was Altaba Inc: 9,835,232 shares worth $536M.
- Jeff Yass added most to Apple in Q2 2017, an estimated $781M increase.
- Jeff Yass's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $353M.
- Jeff Yass fully exited Alphabet (Google) Class C in Q2 2017, selling an estimated $261M.
- Jeff Yass's ten largest holdings make up 22% of its $228B portfolio in Q2 2017.
- Jeff Yass opened 1,702 new positions and closed 1,419 in Q2 2017.
- Jeff Yass's portfolio value rose 15% quarter-over-quarter to $228B.
Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.